The China Mail - Who should get paid for nature's sequenced genes?

USD -
AED 3.6724
AFN 69.999979
ALL 84.721651
AMD 384.280265
ANG 1.789623
AOA 915.999848
ARS 1162.562297
AUD 1.54345
AWG 1.8
AZN 1.69767
BAM 1.68999
BBD 2.018345
BDT 122.251649
BGN 1.70392
BHD 0.37704
BIF 2941
BMD 1
BND 1.280497
BOB 6.932605
BRL 5.499802
BSD 0.999581
BTN 86.165465
BWP 13.364037
BYN 3.271364
BYR 19600
BZD 2.007889
CAD 1.36717
CDF 2876.999994
CHF 0.8158
CLF 0.024638
CLP 945.480101
CNY 7.184992
CNH 7.191804
COP 4100.83
CRC 503.419642
CUC 1
CUP 26.5
CVE 95.37498
CZK 21.616967
DJF 177.719855
DKK 6.491796
DOP 59.349636
DZD 130.160973
EGP 50.147004
ERN 15
ETB 134.30253
EUR 0.87051
FJD 2.251298
FKP 0.735417
GBP 0.744735
GEL 2.720327
GGP 0.735417
GHS 10.309772
GIP 0.735417
GMD 71.512449
GNF 8655.999642
GTQ 7.677452
GYD 209.05827
HKD 7.849695
HNL 26.150234
HRK 6.562303
HTG 130.823436
HUF 351.660317
IDR 16560.1
ILS 3.51285
IMP 0.735417
INR 86.58905
IQD 1310
IRR 42124.999992
ISK 125.010401
JEP 0.735417
JMD 159.096506
JOD 0.709049
JPY 145.2865
KES 129.498893
KGS 87.450311
KHR 4019.999726
KMF 428.999583
KPW 900.005137
KRW 1381.650273
KWD 0.30648
KYD 0.833071
KZT 518.62765
LAK 21575.000211
LBP 89599.999589
LKR 300.634675
LRD 199.650307
LSL 18.019686
LTL 2.95274
LVL 0.60489
LYD 5.42501
MAD 9.124976
MDL 17.073582
MGA 4434.999776
MKD 53.557596
MMK 2098.952839
MNT 3582.467491
MOP 8.082384
MRU 39.719905
MUR 45.379845
MVR 15.404955
MWK 1736.000409
MXN 19.01985
MYR 4.245502
MZN 63.950068
NAD 18.020069
NGN 1543.339904
NIO 36.300769
NOK 9.94245
NPR 137.864917
NZD 1.663022
OMR 0.384641
PAB 0.999581
PEN 3.612497
PGK 4.121897
PHP 56.978036
PKR 283.274977
PLN 3.72125
PYG 7985.068501
QAR 3.6405
RON 4.380702
RSD 102.035956
RUB 78.49084
RWF 1425
SAR 3.751818
SBD 8.347391
SCR 14.292743
SDG 600.495489
SEK 9.540345
SGD 1.286301
SHP 0.785843
SLE 22.475
SLL 20969.503664
SOS 571.508796
SRD 38.850126
STD 20697.981008
SVC 8.746333
SYP 13001.896779
SZL 18.019572
THB 32.569944
TJS 9.901191
TMT 3.5
TND 2.942501
TOP 2.342102
TRY 39.505019
TTD 6.786574
TWD 29.659759
TZS 2596.681991
UAH 41.534467
UGX 3593.756076
UYU 41.070618
UZS 12729.999882
VES 102.0293
VND 26081.5
VUV 119.91429
WST 2.751779
XAF 566.806793
XAG 0.026936
XAU 0.000295
XCD 2.70255
XDR 0.70726
XOF 566.811691
XPF 104.375029
YER 242.698588
ZAR 18.02625
ZMK 9001.194587
ZMW 24.335406
ZWL 321.999592
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: © AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

Y.Su--ThChM